SCHEMBL4480239

SCHEMBL4480239

Cc1cc(=O)c(-c2c[nH]c(-c3ccc4c(c3)OCO4)cc2=O)c(C)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.47
PDE10A Q9Y233 2/20 0.46
KDM4E B2RXH2 3/20 0.39
ALDH1A1 P00352 3/20 0.39
PKM P14618 1/20 0.39
HPGD P15428 1/20 0.39
ALOX5 P09917 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 1/20 0.38
MAPT P10636 2/20 0.36
TRPV1 Q8NER1 1/20 0.36
PTPRC P08575 1/20 0.36
USP2 O75604 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3395826 0.76 CSF1R (0.33) BRD4ALDH1A1
SCHEMBL4480243 0.76 BRD4 (0.47) BRD4PDE10AKDM4EALDH1A1PKM
SCHEMBL3570396 0.67 PTPRC (0.50) BRD4PDE10AKDM4EALDH1A1PKM
SCHEMBL17520498 0.67 ALDH1A1 (0.57) PDE10AKDM4EALDH1A1ALOX5SMN1; SMN2
SCHEMBL15328790 0.64 BRD4 (1.00) BRD4
SCHEMBL15425091 0.64 ADORA2A (0.51) PDE10AKDM4EALDH1A1PKMHPGD
SCHEMBL15328469 0.63 BRD4 (1.00) BRD4KDM4EALDH1A1PKMHPGD
SCHEMBL4490544 0.63 BRD4 (0.39) BRD4MAPTGAAHTTRAB9A
SCHEMBL640039 0.62 DCUN1D1 (0.48) PDE10AKDM4EALDH1A1HPGDALOX5
SCHEMBL9455121 0.62 ALDH1A1 (0.46) BRD4KDM4EALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7579353-B2 Pyridinone derivatives against malaria GLAXO GROUP LIMITED (GB) 2009-08-25 US disclosed
US-20080287461-A1 Pyridinone Derivatives Against Malaria GLAXO GROUP LIMITED (GB) 2008-11-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080287461-A1 Pyridinone Derivatives Against Malaria G6PD, PNPO, PLPBP BRD4 2655/4885PDE10A 1721/4885KDM4E 1311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.